Search Results - "Vakil, Mohammad Kazem"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment by Bahmanyar, Maryam, Vakil, Mohammad Kazem, Al-Awsi, Ghaidaa Raheem Lateef, Kouhpayeh, Seyed Amin, Mansoori, Yaser, Mansoori, Behnam, Moravej, Ali, Mazarzaei, Abdulbaset, Ghasemian, Abdolmajid

    Published in BMC cancer (25-11-2022)
    “…Owing to non-responsiveness of a high number of patients to the common melanoma therapies, seeking novel approaches seem as an unmet requirement. Chimeric…”
    Get full text
    Journal Article
  2. 2

    Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance by Aria, Hamid, Rezaei, Marzieh, Nazem, Shima, Daraei, Abdolreza, Nikfar, Ghasem, Mansoori, Behnam, Bahmanyar, Maryam, Tavassoli, Alireza, Vakil, Mohammad Kazem, Mansoori, Yaser

    Published in Frontiers in immunology (22-08-2022)
    “…ATP and other nucleoside phosphates have specific receptors named purinergic receptors. Purinergic receptors and ectonucleotidases regulate various signaling…”
    Get full text
    Journal Article
  3. 3

    Metallic Nanoparticles: Their Potential Role in Breast Cancer Immunotherapy via Trained Immunity Provocation by Zarenezhad, Elham, Kanaan, Manal Hadi Ghaffoori, Abdollah, Sura Saad, Vakil, Mohammad Kazem, Marzi, Mahrokh, Mazarzaei, Abdulbaset, Ghasemian, Abdolmajid

    Published in Biomedicines (23-04-2023)
    “…Owing to drawbacks in the current common cancer therapies including surgery, chemotherapy and radiotherapy, the development of more reliable, low toxic,…”
    Get full text
    Journal Article
  4. 4

    Paxlovid: Mechanism of Action, Synthesis, and In Silico Study by Marzi, Mahrokh, Vakil, Mohammad Kazem, Bahmanyar, Maryam, Zarenezhad, Elham

    Published in BioMed research international (07-07-2022)
    “…In this work, the discovery and description of PF-07321332, a major bioavailable oral SARS-CoV-2 protease inhibitor with in vitro human coronavirus antiviral…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Applications of Metallic Nanoparticles in the Skin Cancer Treatment by Marzi, Mahrokh, Osanloo, Mahmoud, Vakil, Mohammad Kazem, Mansoori, Yaser, Ghasemian, Abdolmajid, Dehghan, Azizallah, Zarenezhad, Elham

    Published in BioMed research international (14-11-2022)
    “…Skin cancer is one of leading cancers globally, divided into two major categories including melanoma and nonmelanoma. Skin cancer is a global concern with an…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment by Bahmanyar, Maryam, Vakil, Mohammad Kazem, Al-Awsi, Ghaidaa Raheem Lateef, Kouhpayeh, Seyed Amin, Mansoori, Yaser, Mansoori, Behnam, Moravej, Ali, Mazarzaei, Abdulbaset, Ghasemian, Abdolmajid

    Published in BMC cancer (25-11-2022)
    “…Owing to non-responsiveness of a high number of patients to the common melanoma therapies, seeking novel approaches seem as an unmet requirement. Chimeric…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Expression Changes of CX3CL1 and Interleukin-6 Genes During Remission Induction Therapy in Patients with Acute Myeloid Leukemia by Vakil, Mohammad Kazem, Iravani Saadi, Mahdiyar, Ramzi, Mani, Karimi, Aliasghar, Owjfard, Maryam, Torkamani, Mahmoud, Kheradmand, Nadiya, Niknam, Ahmad, Karimi, Zahed, Yazdanpanah, Mohammad Hosein

    Published in Galen (31-12-2021)
    “…Background: Acute myeloid leukemia (AML) syndrome is a hematologic malignancy due to the extensive clonal proliferation of leukemic precursor cells and is…”
    Get full text
    Journal Article
  11. 11

    The Expression Changes of CX3CL1 and Interlukin-6 Genes During Remission Induction Therapy in Patients With Acute Myeloid Leukemia by Iravani Saadi, Mahdiyar, Ramzi, Mani, Karimi, Aliasghar, Owjfard, Maryam, Torkamani, Mahmoud, Kheradmand, Nadiya, Niknam, Ahmad, Karimi, Zahed, Vakil, Mohammad Kazem, Yazdanpanah, Mohammad Hosein

    Published in Galen (31-12-2021)
    “…Background: Acute Myeloid Leukemia syndrome (AML) is a hematologic malignancy which is due to clonal extensive proliferation of leukemic precursor cells and is…”
    Get full text
    Journal Article